Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

Over a two-day-long FDA meeting, an agency panel of advisors considered dueling proposals for new renal denervation therapies—ultimately handing a thumbs-up to Otsuka’s ReCor Medical division, while ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

More than 370,000 insured patients in the United States underwent surgery for ureteral and kidney stones in 2019, highlighting the importance of the 2026 AUA guideline.

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

Medtronic suffered yet another disappointment in its relentless pursuit of bringing renal denervation to market for people living with uncontrolled high blood pressure. There seems to be no question ...

Standardizing follow-up after kidney stone treatment may reduce ionizing radiation exposure, identify recurrences earlier, and avoid complications such as urosepsis and chronic kidney disease, ...